These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7614478)

  • 21. Genetic divergence in the clonal evolution of breast cancer.
    Fujii H; Marsh C; Cairns P; Sidransky D; Gabrielson E
    Cancer Res; 1996 Apr; 56(7):1493-7. PubMed ID: 8603391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.
    Larson PS; de las Morenas A; Cerda SR; Bennett SR; Cupples LA; Rosenberg CL
    J Pathol; 2006 Jul; 209(3):307-16. PubMed ID: 16604511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers.
    Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J
    Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis.
    Selim AG; Ryan A; El-Ayat G; Wells CA
    J Pathol; 2002 Mar; 196(3):287-91. PubMed ID: 11857491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic pathways in the evolution of breast ductal carcinoma in situ.
    Farabegoli F; Champeme MH; Bieche I; Santini D; Ceccarelli C; Derenzini M; Lidereau R
    J Pathol; 2002 Mar; 196(3):280-6. PubMed ID: 11857490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer.
    Flagiello D; Gerbault-Seureau M; Sastre-Garau X; Padoy E; Vielh P; Dutrillaux B
    Genes Chromosomes Cancer; 1998 Dec; 23(4):300-6. PubMed ID: 9824202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of loss heterozygosity in primary and recurrent ductal carcinoma in situ of the breast.
    Lininger RA; Fujii H; Man YG; Gabrielson E; Tavassoli FA
    Mod Pathol; 1998 Dec; 11(12):1151-9. PubMed ID: 9872644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary lesions of the breast: a molecular progression?
    Di Cristofano C; Mrad K; Zavaglia K; Bertacca G; Aretini P; Cipollini G; Bevilacqua G; Ben Romdhane K; Cavazzana A
    Breast Cancer Res Treat; 2005 Mar; 90(1):71-6. PubMed ID: 15770529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
    Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
    Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
    Hansen LL; Yilmaz M; Overgaard J; Andersen J; Kruse TA
    Cancer Res; 1998 May; 58(10):2166-9. PubMed ID: 9605761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of two separate regions on chromosome 3p in breast cancers.
    Chen LC; Matsumura K; Deng G; Kurisu W; Ljung BM; Lerman MI; Waldman FM; Smith HS
    Cancer Res; 1994 Jun; 54(11):3021-4. PubMed ID: 7910519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.
    Yoshida M; Tsuda H; Yamamoto S; Kinoshita T; Akashi-Tanaka S; Hojo T; Fukutomi T
    Virchows Arch; 2012 May; 460(5):497-504. PubMed ID: 22476400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic significance of loss of heterozygosity in breast cancer].
    Iwase H; Iwata H; Toyama T; Hara Y; Omoto Y; Kobayashi S
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():426-30. PubMed ID: 9589047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.